source
- STAT+: Hims’ sales miss as telehealth competition growsBristol's partnership with Hengrui Pharma, Viiv loses HIV treatment case, and more biotech news from The ReadoutSTAT · 3mo ago↗ source
- Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugA deal with Rigel Pharmaceuticals ends months of uncertainty about the future of Veppanu, a first-of-its-kind, newly approved medicine with a murky financial outlook.BioPharma Dive · 3mo ago↗ source
- Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence RiskA Fox Chase Cancer Center study will evaluate a tumor-informed, whole-genome sequencing–based test to assess recurrence risk in early-stage NSCLC.